17214329

Source:http://linkedlifedata.com/resource/pubmed/id/17214329

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0007131, umls-concept:C0008838, umls-concept:C0123931, umls-concept:C0332174, umls-concept:C0701185
pubmed:issue	6C
pubmed:dateCreated	2007-1-11
pubmed:abstractText	Weekly administration of irinotecan plus cisplatin was evaluated for untreated patients with non-small cell lung cancer (NSCLC).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8102988
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status	MEDLINE
pubmed:issn	0250-7005
pubmed:author	pubmed-author:East Japan Chesters Group, pubmed-author:GemmaAkihikoA, pubmed-author:HinoMitsunoriM, pubmed-author:HisakatsuShojiS, pubmed-author:KobayashiKunihikoK, pubmed-author:KudohShojiS, pubmed-author:MoriyaHiroshiH, pubmed-author:TakedaYuichiroY, pubmed-author:YonedaShuichiS, pubmed-author:YoshimuraAkinobuA
pubmed:issnType	Print
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4697-703
pubmed:meshHeading	pubmed-meshheading:17214329-Adult, pubmed-meshheading:17214329-Aged, pubmed-meshheading:17214329-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17214329-Camptothecin, pubmed-meshheading:17214329-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:17214329-Cisplatin, pubmed-meshheading:17214329-Drug Administration Schedule, pubmed-meshheading:17214329-Female, pubmed-meshheading:17214329-Humans, pubmed-meshheading:17214329-Lung Neoplasms, pubmed-meshheading:17214329-Male, pubmed-meshheading:17214329-Middle Aged, pubmed-meshheading:17214329-Survival Rate
pubmed:articleTitle	Weekly administration of irinotecan (CPT-11) plus cisplatin for non-small cell lung cancer.
pubmed:affiliation	Division of Internal Medicine, Chiba-Hokuso Hospital of Nippon Medical School, 1715 Imbamura-Kamakari, Imba-Gun, Chiba.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study